ARC Desk

Hormonal Contraceptives Market Worth Nearly $26.5 Bn by 2026

Lehdistötiedote   •   Marras 06, 2019 13:51 EET

The global Hormonal Contraceptives Market is projected to grow at an annual rate of almost 4.2% over the forecast time frame 2019 to 2026, according to ARC. The global based market intelligence company expects the market to reach a value of around $26.5 billion by 2026.

Acumen Research and Consulting has recently published a research report on the Hormonal Contraceptives Market for the forecast period of 2019 to 2026, The report provides rational insights along with historical and forecast data that aids in better understanding of the global scenario of Hormonal Contraceptives Market. The report provides a comprehensive analysis of the factors that are expected to drive and restrict the growth of the market. It also provides the detailed overview of the opportunities that are present in the market along with the current trends observed in the target market. The report includes a complete study of quantitative analysis of the industry for the period of 8 years in order to assist players to take advantage of the report. The report includes widespread analysis of the key segments of the industry that help for better understanding of the current trends and opportunities in this research report.

The Porters Five Forces analysis is included in the report, provides insights on the overall scenario from buyers and suppliers point-of-view. The regulatory compliances provide insight of the various government rules and regulations on various products and services and the way it affects the various end use industry.

Market Participants / Key Players:

The report cover the major players operating in the target market along with the key strategies adopted in order to get a competitive edge against the competitors which provides a competitive outlook of the industry. The report provides a competitive landscape that includes insights of the positioning of players on global level through mapping the business and product offering strength.

Several players, including Allergan; Pfizer; Afaxys, Inc.; Agile Therapeutics; Bayer AG; Merck & Co. Inc.; Teva Pharmaceuticals Industries Ltd.; and Apothecus Pharmaceutical Corporation. companies, research institutes, contract manufacturing organizations, and non-profit organizations, are playing a critical role in the development and production of these vectors.

Download Free Sample Report Pages for Better Understanding@ https://www.acumenresearchandconsulting.com/request-sample/1482

Scope of the Hormonal Contraceptives Market Report:

The study provides a decisive view of the Hormonal Contraceptives Market by segmenting it in terms of form and application. The segment has been analyzed based on the present and future trends. Regional segmentation includes the current and projected demand in North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. It also provides country wise segmentation and the factors that are driving the regional growth.

Market Segmentation:

Market, By Product Type

  • Oral Contraceptive Pills
  • Vaginal Rings
  • Emergency Contraceptive Pills
  • Transdermal Patches
  • Injectable Birth Control

Market, By Hormone

  • Combined Hormonal Contraceptive
  • Progestin-only Contraceptive

Market, By End User

  • Hospitals
  • Clinics
  • Household

Market, By Geography

  • North America.
  • Europe
  • Asia-Pacific
  • Latin America
  • Middle East and Africa (MEA)

The market research study on “Hormonal Contraceptives Market - Global Industry Analysis, Market Size, Opportunities and Forecast, 2019 - 2026” offers detailed insights on global Hormonal contraceptives market segments with market dynamics and their impact. The report also covers basic technology development policies.

Key Questions Answered in the Report

The report addresses key questions concerning the market evolution and overarching trends shaping global market growth. Some of the key questions answered in the report include-

  • What is the overall structure of the market?
  • What was the historical value and what is the forecasted value of the market?
  • What are the key product level trends in the market?
  • What are the market level trends in the market?
  • Which of the market players are leading and what are their key differential strategies to retain their stronghold?
  • Which are the most lucrative regions in the market space?

Would like to place an order or any question, please feel free to contact at sales@acumenresearchandconsulting.com | +1 407 915 4157

TABLE OF CONTENT

CHAPTER 1. INDUSTRY OVERVIEW

1.1. Definition and Scope
1.1.1. Definition of Hormonal Contraceptives
1.1.2. Market Segmentation
1.1.3. List of Abbreviations
1.2. Summary
1.2.1. Market Snapshot
1.2.2. Hormonal Contraceptives Market By Product Type
1.2.2.1. Global Hormonal Contraceptives Market Revenue and Growth Rate Comparison By Product Type (2015-2026)
1.2.2.2. Global Hormonal Contraceptives Market Revenue Share By Product Type in 2017
1.2.2.3. Oral Contraceptive Pills
1.2.2.4. Vaginal Rings
1.2.2.5. Emergency Contraceptive Pills
1.2.2.6. Transdermal Patches
1.2.2.7. Injectable Birth Control
1.2.3. Hormonal Contraceptives Market By Hormone
1.2.3.1. Global Hormonal Contraceptives Market Revenue and Growth Rate Comparison By Hormone (2015-2026)
1.2.3.2. Combined Hormonal Contraceptive
1.2.3.3. Progestin-only Contraceptive
1.2.4. Hormonal Contraceptives Market By End User
1.2.4.1. Global Hormonal Contraceptives Market Revenue and Growth Rate Comparison By End User (2015-2026)
1.2.4.2. Hospitals
1.2.4.3. Clinics
1.2.4.4. Household
1.2.5. Hormonal Contraceptives Market by Geography
1.2.5.1. Global Hormonal Contraceptives Market Revenue and Growth Rate Comparison by Geography (2015-2026)
1.2.5.2. North America Hormonal Contraceptives Market Revenue and Growth Rate (2015-2026)
1.2.5.3. Europe Hormonal Contraceptives Market Revenue and Growth Rate (2015-2026)
1.2.5.4. Asia-Pacific Hormonal Contraceptives Market Revenue and Growth Rate (2015-2026)
1.2.5.5. Latin America Hormonal Contraceptives Market Revenue and Growth Rate (2015-2026)
1.2.5.6. Middle East and Africa (MEA) Hormonal Contraceptives Market Revenue and Growth Rate (2015-2026)

CHAPTER 2. MARKET DYNAMICS AND COMPETITION ANALYSIS

2.1. Market Drivers
2.2. Restraints and Challenges
2.3. Growth Opportunities
2.4. Porter’s Five Forces Analysis
2.4.1. Bargaining Power of Suppliers
2.4.2. Bargaining Power of Buyers
2.4.3. Threat of Substitute
2.4.4. Threat of New Entrants
2.4.5. Degree of Competition
2.5. Value Chain Analysis
2.6. Cost Structure Analysis
2.6.1. Raw Material and Suppliers
2.6.2. Manufacturing Process Analysis
2.7. Regulatory Compliance
2.8. Competitive Landscape, 2017
2.8.1. Player Positioning Analysis
2.8.2. Key Strategies Adopted By Leading Players

CHAPTER 3. MANUFACTURING PLANTS ANALYSIS

3.1. Capacity and Commercial Production Date of Global Hormonal Contraceptives Major Manufacturers in 2017
3.2. Manufacturing Plants Distribution of Global Hormonal Contraceptives Major Manufacturers in 2017
3.3. R&D Status and Technology Product Type of Global Hormonal Contraceptives Major Manufacturers in 2017
3.4. Raw Materials Sources Analysis of Global Hormonal Contraceptives Major Manufacturers in 2017

CHAPTER 4. HORMONAL CONTRACEPTIVES MARKET BY PRODUCT TYPE

4.1. Global Hormonal Contraceptives Revenue By Product Type
4.2. Oral Contraceptive Pills
4.2.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
4.2.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
4.3. Vaginal Rings
4.3.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
4.3.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
4.4. Emergency Contraceptive Pills
4.4.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
4.4.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
4.5. Transdermal Patches
4.5.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
4.5.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
4.6. Injectable Birth Control
4.6.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
4.6.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)

CHAPTER 5. HORMONAL CONTRACEPTIVES MARKET BY HORMONE

5.1. Global Hormonal Contraceptives Revenue By Hormone
5.2. Combined Hormonal Contraceptive
5.2.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
5.2.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
5.3. Progestin-only Contraceptive
5.3.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
5.3.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)

CHAPTER 6. HORMONAL CONTRACEPTIVES MARKET BY END USER

6.1. Global Hormonal Contraceptives Revenue By End User
6.2. Hospitals
6.2.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
6.2.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
6.3. Clinics
6.3.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
6.3.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
6.4. Household
6.4.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
6.4.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)

CHAPTER 7. NORTH AMERICA HORMONAL CONTRACEPTIVES MARKET BY COUNTRY

7.1. North America Hormonal Contraceptives Market Revenue and Growth Rate, 2015 - 2026 ($Million)
7.2. North America Hormonal Contraceptives Market Revenue Share Comparison, 2015 & 2026 (%)
7.3. U.S.
7.3.1. U.S. Hormonal Contraceptives Market Revenue and Forecast By Product Type, 2015 - 2026 ($Million)
7.3.2. Market Revenue and Forecast By Hormone, 2015 - 2026 ($Million)
7.3.3. Market Revenue and Forecast By End User, 2015 - 2026 ($Million)
7.4. Canada
7.4.1. Market Revenue and Forecast By Product Type, 2015 - 2026 ($Million)
7.4.2. Market Revenue and Forecast By Hormone, 2015 - 2026 ($Million)
7.4.3. Market Revenue and Forecast By End User, 2015 - 2026 ($Million)
7.5. Mexico
7.5.1. Market Revenue and Forecast By Product Type, 2015 - 2026 ($Million)
7.5.2. Market Revenue and Forecast By Hormone, 2015 - 2026 ($Million)
7.5.3. Market Revenue and Forecast By End User, 2015 - 2026 ($Million)

CHAPTER 8. EUROPE HORMONAL CONTRACEPTIVES MARKET BY COUNTRY

8.1. Europe Hormonal Contraceptives Market Revenue and Growth Rate, 2015 - 2026 ($Million)
8.2. Europe Hormonal Contraceptives Market Revenue Share Comparison, 2015 & 2026 (%)
8.3. UK
8.3.1. Market Revenue and Forecast By Product Type, 2015 - 2026 ($Million)
8.3.2. Market Revenue and Forecast By Hormone, 2015 - 2026 ($Million)
8.3.3. Market Revenue and Forecast By End User, 2015 - 2026 ($Million)
8.4. Germany
8.4.1. Market Revenue and Forecast By Product Type, 2015 - 2026 ($Million)
8.4.2. Market Revenue and Forecast By Hormone, 2015 - 2026 ($Million)
8.4.3. Market Revenue and Forecast By End User, 2015 - 2026 ($Million)
8.5. France
8.5.1. Market Revenue and Forecast By Product Type, 2015 - 2026 ($Million)
8.5.2. Market Revenue and Forecast By Hormone, 2015 - 2026 ($Million)
8.5.3. Market Revenue and Forecast By End User, 2015 - 2026 ($Million)
8.6. Spain
8.6.1. Market Revenue and Forecast By Product Type, 2015 - 2026 ($Million)
8.6.2. Market Revenue and Forecast By Hormone, 2015 - 2026 ($Million)
8.6.3. Market Revenue and Forecast By End User, 2015 - 2026 ($Million)
8.7. Rest of Europe
8.7.1. Market Revenue and Forecast By Product Type, 2015 - 2026 ($Million)
8.7.2. Market Revenue and Forecast By Hormone, 2015 - 2026 ($Million)
8.7.3. Market Revenue and Forecast By End User, 2015 - 2026 ($Million)

CHAPTER 9. ASIA-PACIFIC HORMONAL CONTRACEPTIVES MARKET BY COUNTRY

9.1. Asia-Pacific Hormonal Contraceptives Market Revenue and Growth Rate, 2015 - 2026 ($Million)
9.2. Asia-Pacific Hormonal Contraceptives Market Revenue Share Comparison, 2015 & 2026 (%)
9.3. China
9.3.1. Market Revenue and Forecast By Product Type, 2015 - 2026 ($Million)
9.3.2. Market Revenue and Forecast By Hormone, 2015 - 2026 ($Million)
9.3.3. Market Revenue and Forecast By End User, 2015 - 2026 ($Million)
9.4. Japan
9.4.1. Market Revenue and Forecast By Product Type, 2015 - 2026 ($Million)
9.4.2. Market Revenue and Forecast By Hormone, 2015 - 2026 ($Million)
9.4.3. Market Revenue and Forecast By End User, 2015 - 2026 ($Million)
9.5. India
9.5.1. Market Revenue and Forecast By Product Type, 2015 - 2026 ($Million)
9.5.2. Market Revenue and Forecast By Hormone, 2015 - 2026 ($Million)
9.5.3. Market Revenue and Forecast By End User, 2015 - 2026 ($Million)
9.6. Australia
9.6.1. Market Revenue and Forecast By Product Type, 2015 - 2026 ($Million)
9.6.2. Market Revenue and Forecast By Hormone, 2015 - 2026 ($Million)
9.6.3. Market Revenue and Forecast By End User, 2015 - 2026 ($Million)
9.7. South Korea
9.7.1. Market Revenue and Forecast By Product Type, 2015 - 2026 ($Million)
9.7.2. Market Revenue and Forecast By Hormone, 2015 - 2026 ($Million)
9.7.3. Market Revenue and Forecast By End User, 2015 - 2026 ($Million)
9.8. Rest of Asia-Pacific
9.8.1. Market Revenue and Forecast By Product Type, 2015 - 2026 ($Million)
9.8.2. Market Revenue and Forecast By Hormone, 2015 - 2026 ($Million)
9.8.3. Market Revenue and Forecast By End User, 2015 - 2026 ($Million)

CHAPTER 10. LATIN AMERICA HORMONAL CONTRACEPTIVES MARKET BY COUNTRY

10.1. Latin America Hormonal Contraceptives Market Revenue and Growth Rate, 2015 - 2026 ($Million)
10.2. Latin America Hormonal Contraceptives Market Revenue Share Comparison, 2015 & 2026 (%)
10.3. Brazil
10.3.1. Market Revenue and Forecast By Product Type, 2015 - 2026 ($Million)
10.3.2. Market Revenue and Forecast By Hormone, 2015 - 2026 ($Million)
10.3.3. Market Revenue and Forecast By End User, 2015 - 2026 ($Million)
10.4. Argentina
10.4.1. Market Revenue and Forecast By Product Type, 2015 - 2026 ($Million)
10.4.2. Market Revenue and Forecast By Hormone, 2015 - 2026 ($Million)
10.4.3. Market Revenue and Forecast By End User, 2015 - 2026 ($Million)
10.5. Rest of Latin America
10.5.1. Market Revenue and Forecast By Product Type, 2015 - 2026 ($Million)
10.5.2. Market Revenue and Forecast By Hormone, 2015 - 2026 ($Million)
10.5.3. Market Revenue and Forecast By End User, 2015 - 2026 ($Million)

CHAPTER 11. MIDDLE EAST HORMONAL CONTRACEPTIVES MARKET BY COUNTRY

11.1. Middle East Hormonal Contraceptives Market Revenue and Growth Rate, 2015 - 2026 ($Million)
11.2. Middle East Hormonal Contraceptives Market Revenue Share Comparison, 2015 & 2026 (%)
11.3. Saudi Arabia
11.3.1. Market Revenue and Forecast By Product Type, 2015 - 2026 ($Million)
11.3.2. Market Revenue and Forecast By Hormone, 2015 - 2026 ($Million)
11.3.3. Market Revenue and Forecast By End User, 2015 - 2026 ($Million)
11.4. UAE
11.4.1. Market Revenue and Forecast By Product Type, 2015 - 2026 ($Million)
11.4.2. Market Revenue and Forecast By Hormone, 2015 - 2026 ($Million)
11.4.3. Market Revenue and Forecast By End User, 2015 - 2026 ($Million)
11.5. Rest of Middle East
11.5.1. Market Revenue and Forecast By Product Type, 2015 - 2026 ($Million)
11.5.2. Market Revenue and Forecast By Hormone, 2015 - 2026 ($Million)
11.5.3. Market Revenue and Forecast By End User, 2015 - 2026 ($Million)

CHAPTER 12. AFRICA HORMONAL CONTRACEPTIVES MARKET BY COUNTRY

12.1. Africa Hormonal Contraceptives Market Revenue and Growth Rate, 2015 - 2026 ($Million)
12.2. Africa Hormonal Contraceptives Market Revenue Share Comparison, 2015 & 2026 (%)
12.3. South Africa
12.3.1. Market Revenue and Forecast By Product Type, 2015 - 2026 ($Million)
12.3.2. Market Revenue and Forecast By Hormone, 2015 - 2026 ($Million)
12.3.3. Market Revenue and Forecast By End User, 2015 - 2026 ($Million)
12.4. Egypt
12.4.1. Market Revenue and Forecast By Product Type, 2015 - 2026 ($Million)
12.4.2. Market Revenue and Forecast By Hormone, 2015 - 2026 ($Million)
12.4.3. Market Revenue and Forecast By End User, 2015 - 2026 ($Million)
12.5. Rest of Africa
12.5.1. Market Revenue and Forecast By Product Type, 2015 - 2026 ($Million)
12.5.2. Market Revenue and Forecast By Hormone, 2015 - 2026 ($Million)
12.5.3. Market Revenue and Forecast By End User, 2015 - 2026 ($Million)

CHAPTER 13. COMPANY PROFILE

13.1. Allergan
13.1.1. Company Snapshot
13.1.2. Overview
13.1.3. Financial Overview
13.1.4. Type Portfolio
13.1.5. Key Developments
13.1.6. Strategies
13.2. Pfizer
13.2.1. Company Snapshot
13.2.2. Overview
13.2.3. Financial Overview
13.2.4. Type Portfolio
13.2.5. Key Developments
13.2.6. Strategies
13.3. Afaxys, Inc.
13.3.1. Company Snapshot
13.3.2. Overview
13.3.3. Financial Overview
13.3.4. Type Portfolio
13.3.5. Key Developments
13.3.6. Strategies
13.4. Agile Therapeutics
13.4.1. Company Snapshot
13.4.2. Overview
13.4.3. Financial Overview
13.4.4. Type Portfolio
13.4.5. Key Developments
13.4.6. Strategies
13.5. Bayer AG
13.5.1. Company Snapshot
13.5.2. Overview
13.5.3. Financial Overview
13.5.4. Type Portfolio
13.5.5. Key Developments
13.5.6. Strategies
13.6. Merck & Co. Inc.
13.6.1. Company Snapshot
13.6.2. Overview
13.6.3. Financial Overview
13.6.4. Type Portfolio
13.6.5. Key Developments
13.6.6. Strategies
13.7. Teva Pharmaceuticals Industries Ltd.
13.7.1. Company Snapshot
13.7.2. Overview
13.7.3. Financial Overview
13.7.4. Type Portfolio
13.7.5. Key Developments
13.7.6. Strategies
13.8. Apothecus Pharmaceutical Corporation
13.8.1. Company Snapshot
13.8.2. Overview
13.8.3. Financial Overview
13.8.4. Type Portfolio
13.8.5. Key Developments
13.8.6. Strategies
13.9. Others
13.9.1. Company Snapshot
13.9.2. Overview
13.9.3. Financial Overview
13.9.4. Type Portfolio
13.9.5. Key Developments
13.9.6. Strategies

CHAPTER 14. RESEARCH APPROACH

14.1. Research Methodology
14.1.1. Initial Data Search
14.1.2. Secondary Research
14.1.3. Primary Research
14.2. Assumptions and Scope

The report is readily available and can be dispatched immediately after payment confirmation.

To Purchase this Premium Report@ https://www.acumenresearchandconsulting.com/buy-now/0/1482

Contact Us:

Acumen Research and Consulting

Email: sales@acumenresearchandconsulting.com

Phone: +1 407 915 4157

Acumen Research and Consulting (ARC) is a global provider of market intelligence and consulting services to information technology, investment, telecommunication, manufacturing, and consumer technology markets. ARC helps investment communities, IT professionals, and business executives to make fact based decisions on technology purchases and develop firm growth strategies to sustain market competition. With the team size of 100+ Analysts and collective industry experience of more than 200 years, Acumen Research and Consulting assures to deliver a combination of industry knowledge along with global and country level expertise.